Narek Abelyan

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 10

Top Topics

Mass Spectrometry

Molecular Dynamics Simulations

Protein Protein

Top Venues

Nanomedicine (London, England)

Antibiotics (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Nelli Ohanyan, Narek Abelyan, Arpi Manukyan, Vardan Hayrapetyan, Samvel Chailyan, Susanna Tiratsuyan, Kristine E Danielyan
Tannin-albumin particles as stable carriers of medicines. Nanomedicine (London, England) 19 (8) (2024)
Nelli Ohanyan, Narek Abelyan, Arpi Manukyan, Vardan Hayrapetyan, Samvel Chailyan, Susanna Tiratsuyan, Kristine E Danielyan
Tannin-albumin particles as stable carriers of medicines. Nanomedicine (London, England) 19 (8) (2024)
Nelli Ohanyan, Narek Abelyan, Arpi Manukyan, Vardan Hayrapetyan, Samvel Chailyan, Susanna Tiratsuyan, Kristine E Danielyan
Tannin-albumin particles as stable carriers of medicines. Nanomedicine (London, England) 19 (8) (2024)
Nelli Ohanyan, Narek Abelyan, Arpi Manukyan, Vardan Hayrapetyan, Samvel Chailyan, Susanna Tiratsuyan, Kristine E Danielyan
Tannin-albumin particles as stable carriers of medicines. Nanomedicine (London, England) (2024)
Shaimaa R Ahmed, Mohammad M Al-Sanea, Ehab M Mostafa, Sumera Qasim, Narek Abelyan, Fatma Alzahraa Mokhtar
A Network Pharmacology Analysis of Cytotoxic Triterpenes Isolated from Euphorbia abyssinica Latex Supported by Drug-likeness and ADMET Studies. ACS omega 7 (21) (2022)
Shaimaa R Ahmed, Ahmed R Hamed, Mohammed I Ali, Mohamed S Sedeek, Narek Abelyan, Mohammad M Al-Sanea
Cancer Chemopreventive Potential and Chemical Profiling of Euphorbia abyssinica Endowed with Docking Studies. ACS omega 7 (4) (2022)
Mohammad M Al-Sanea, Garri Chilingaryan, Narek Abelyan, Michael Mamikonyan, Hayk Gasparyan, Sargis Hovhannisyan, Abdelrahman Hamdi, Ahmed R Ali, Samy Selim, Ahmed A B Mohamed
Combination of ligand and structure based virtual screening approaches for the discovery of potential PARP1 inhibitors. PloS one 17 (9) (2022)
Mohammad M Al-Sanea, Garri Chilingaryan, Narek Abelyan, Arsen Sargsyan, Sargis Hovhannisyan, Hayk Gasparyan, Smbat Gevorgyan, Sarah M Albogami, Mohammed M Ghoneim, Ahmed K Farag, Ahmed A B Mohamed, Ashraf K El-Damasy
Identification of Novel Potential VEGFR-2 Inhibitors Using a Combination of Computational Methods for Drug Discovery. Life (Basel, Switzerland) 11 (10) (2021)
Mohammad M Al-Sanea, Narek Abelyan, Mohamed Abdelwahab Abdelgawad, Arafa Musa, Mohammed M Ghoneim, Tarfah Al-Warhi, Nada Aljaeed, Ohoud J Alotaibi, Taghreed S Alnusaire, Sayed F Abdelwahab, Aya Helmy, Usama Ramadan Abdelmohsen, Khayrya A Youssif
Strawberry and Ginger Silver Nanoparticles as Potential Inhibitors for SARS-CoV-2 Assisted by In Silico Modeling and Metabolic Profiling. Antibiotics (Basel, Switzerland) 10 (7) (2021)
Harutyun Sahakyan, Narek Abelyan, Vahram Arakelov, Grigor Arakelov, Karen Nazaryan
In silico study of colchicine resistance molecular mechanisms caused by tubulin structural polymorphism. PloS one 14 (8) (2019)